Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002)
一项多中心回顾性研究（GUIDANCE002）表明，新辅助经动脉化疗栓塞联合酪氨酸激酶和免疫检查点抑制剂可提高可切除肝细胞癌患者的生存率。
期刊:
影响因子:
doi:10.1038/s43856-025-01303-w
Yang, Da-Long; Qin, Chuang; Peng, Ning; Liu, Shao-Ping; Yu, Ya-Qun; Nong, Jun-Liang; Zeng, Fan-Jian; Su, Ze; Yang, Yong-Yu; Yang, Fu-Quan; Li, Mian-Jing; Wu, Ming-Song; Wang, Xue-Yao; Liang, Yong-Rong; Li, Fu-Xin; Chen, Shu-Chang; Lai, Yong-Cheng; Pang, Qing-Qing; Zhong, Teng-Meng; Yan, Yi-He; Zhang, Ying-Yu; Ye, Lin; Dong, Xiao-Feng; Li, Wen-Feng; Liu, Jie; Yao, Hong-Bing; Wu, Pei-Sheng; Mao, Xian-Shuang; Ou, Jun-Jie; Chen, Yao-Zhi; Wang, Guo-Dong; Chen, Kang; Deng, Zhu-Jian; Su, Jia-Yong; Qiu, Guo-Gao; Liu, Zhi-Dong; Wang, Jin-Min; Zhang, Yi; Liang, Xiu-Mei; Xiang, Bang-De; Ma, Liang; Zhong, Jian-Hong
